Kopran Ltd (KPRN)

Currency in INR
207.28
+0.62(+0.30%)
Closed·
KPRN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
202.99216.00
52 wk Range
107.00219.00
Key Statistics
Bid/Ask
207.50 / 207.28
Prev. Close
206.66
Open
203
Day's Range
202.99-216
52 wk Range
107-219
Volume
256.15K
Average Volume (3m)
641.48K
1-Year Change
15.2068%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KPRN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
May 19, 2026
EPS / Forecast
3.91 / --
Revenue / Forecast
2.34B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.33%
Dividend Yield
1.45%
Industry Median 0.71%
Annualised payout
3.00
Paid annually
5-Years Growth
-
Growth Streak

KPRN Income Statement

Compare KPRN to Peers and Sector

Metrics to compare
KPRN
Peers
Sector
Relationship
P/E Ratio
39.1x27.9x−0.4x
PEG Ratio
−1.170.900.00
Price/Book
1.9x2.8x2.6x
Price / LTM Sales
1.5x2.6x3.0x
Upside (Analyst Target)
-5.9%52.8%
Fair Value Upside
Unlock−3.3%9.7%Unlock

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, sterile carbapenem, urological, neuromodulator, antidiabetic, pain management, neuromodular, gastroenterology, and cardiovascular. In addition, the company offers drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others. Kopran Limited was incorporated in 1958 and is based in Mumbai, India.

Employees
1024
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
89.30K0.18%18.45M
Other Institutional Investors
18.89M39.13%3.90B
Public Companies & Retail Investors
29.30M60.68%6.06B
Total
48.29M100.00%9.98B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Oricon Enterprises Limited17.43%8,417,1831,739,495
Panorama Finvest Pvt Ltd7.87%3,800,000785,308

People Also Watch

8,900.50
APLH
+1.34%
4,498.60
GETD
-0.60%
364.90
NALU
+2.73%

FAQ

What Is the Kopran Ltd (KPRN) Stock Price Today?

The Kopran Ltd stock price today is 207.28 INR.

What Stock Exchange Does Kopran Ltd Trade On?

Kopran Ltd is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Kopran Ltd?

The stock symbol for Kopran Ltd is "KPRN."

What Is the Kopran Ltd Market Cap?

As of today, Kopran Ltd market cap is 10.02B INR.

What Is Kopran Ltd's Earnings Per Share (TTM)?

The Kopran Ltd EPS (TTM) is 5.33.

From a Technical Analysis Perspective, Is KPRN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Kopran Ltd Stock Split?

Kopran Ltd has split 0 times.

How Many Employees Does Kopran Ltd Have?

Kopran Ltd has 1024 employees.

What is the current trading status of Kopran Ltd (KPRN)?

As of Jul 14, 2026, Kopran Ltd (KPRN) is trading at a price of 207.28 INR, with a previous close of 206.66 INR. The stock has fluctuated within a day range of 202.99 INR to 216.00 INR, while its 52-week range spans from 107.00 INR to 219.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.